NCT01711879View on ClinicalTrials.gov

Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Neovascular Glaucoma
Interventions
DRUG

Aflibercept

Details covered in arm description

Trial Locations (1)

80045

Rocky Mountain Lions Eye Institute, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01711879 - Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma | Biotech Hunter | Biotech Hunter